ALLO vs QRVO · rev $4.6M vs P/E 27, rev $3.68B
Allogene Therapeutics Inc (ALLO) versus Qorvo Inc (QRVO) — a side-by-side from cached financials, not a winner call.
Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.
Qorvo Inc (QRVO) is a semiconductors company listed on NASDAQ.
Latest reported ALLO revenue for 2026-06-30 was $4.6M. Net income was -$85.3M. ALLO currently screens at market cap $258.1M.
Latest reported QRVO revenue for 2026-03-28 was $3.68B. Net income was $339.0M. Revenue was down 1.1% from 2025-03-29 to 2026-03-28. QRVO currently screens at market cap $8.54B and trailing P/E 26.8.
ALLO currently screens at market cap $258.1M. QRVO currently screens at market cap $8.54B and trailing P/E 26.8.
Not investment advice. Open the ALLO and QRVO stock pages for the full models.
Not investment advice.